Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Haferkamp

Showing results (181-190 of 282) with videos related to

Pageof 29
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 3, 2026
Explainable artificial intelligence in prostate cancer treatment recommendation: A decision support system for oncological expert panelsGregor Duwe, Dominique Mercier, Verena Kauth, et al.
Urologia Internationalis|May 14, 2024
Comparative Retrospective Assessment of the Effectiveness and Risk Factors of Fluoroquinolones, Cephalosporines, and Selective Antibiotic Prophylaxis for Transrectal Prostate BiopsyMaximilian Haack, Christian Ruckes, Robert Dotzauer, et al.
Cancers|March 10, 2022
Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling PathwaySascha D Markowitsch, Olesya Vakhrusheva, Patricia Schupp, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 10, 2018
Websites on Bladder Cancer: an Appropriate Source of Patient Information?Johannes Salem, Pia Paffenholz, Christian Bolenz, et al.
Journal of Cellular and Molecular Medicine|March 27, 2015
Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cellsIgor Tsaur, Lukasz Hudak, Jasmina Makarević, et al.
Cancers|September 28, 2021
Nivolumab Reduces PD1 Expression and Alters Density and Proliferation of Tumor Infiltrating Immune Cells in a Tissue Slice Culture Model of Renal Cell CarcinomaPhilipp J Stenzel, Nina Hörner, Sebastian Foersch, et al.
Frontiers in Oncology|December 13, 2021
Multimodal Deep Learning for Prognosis Prediction in Renal CancerStefan Schulz, Ann-Christin Woerl, Florian Jungmann, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 14, 2015
sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patientsIgor Tsaur, Kristina Thurn, Eva Juengel, et al.
Urologia Internationalis|January 20, 2020
AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPCHolger Hans Herman Erb, Peter Sparwasser, Tamara Diehl, et al.
Urologic Oncology|April 22, 2019
sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitroIgor Tsaur, Tanja Hüsch, Eva Jüngel, et al.
Pageof 29

Showing results (181-190 of 282) with videos related to

Sort By:
Pageof 29
European Journal of Cancer (Oxford, England : 1990)|June 3, 2026
Explainable artificial intelligence in prostate cancer treatment recommendation: A decision support system for oncological expert panelsGregor Duwe, Dominique Mercier, Verena Kauth, et al.
Urologia Internationalis|May 14, 2024
Comparative Retrospective Assessment of the Effectiveness and Risk Factors of Fluoroquinolones, Cephalosporines, and Selective Antibiotic Prophylaxis for Transrectal Prostate BiopsyMaximilian Haack, Christian Ruckes, Robert Dotzauer, et al.
Cancers|March 10, 2022
Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling PathwaySascha D Markowitsch, Olesya Vakhrusheva, Patricia Schupp, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 10, 2018
Websites on Bladder Cancer: an Appropriate Source of Patient Information?Johannes Salem, Pia Paffenholz, Christian Bolenz, et al.
Journal of Cellular and Molecular Medicine|March 27, 2015
Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cellsIgor Tsaur, Lukasz Hudak, Jasmina Makarević, et al.
Cancers|September 28, 2021
Nivolumab Reduces PD1 Expression and Alters Density and Proliferation of Tumor Infiltrating Immune Cells in a Tissue Slice Culture Model of Renal Cell CarcinomaPhilipp J Stenzel, Nina Hörner, Sebastian Foersch, et al.
Frontiers in Oncology|December 13, 2021
Multimodal Deep Learning for Prognosis Prediction in Renal CancerStefan Schulz, Ann-Christin Woerl, Florian Jungmann, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 14, 2015
sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patientsIgor Tsaur, Kristina Thurn, Eva Juengel, et al.
Urologia Internationalis|January 20, 2020
AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPCHolger Hans Herman Erb, Peter Sparwasser, Tamara Diehl, et al.
Urologic Oncology|April 22, 2019
sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitroIgor Tsaur, Tanja Hüsch, Eva Jüngel, et al.
Pageof 29